8 July 2025 Clinical Public Health Hep C trial backs sofosbuvir–daclatasvir as potent first-line option
15 April 2025 Hepatocellular carcinoma Research Three treatments are better than one for liver cancer
24 September 2024 Gastroenterology Research $3m research boost for disorders of gut-brain interaction
24 September 2024 Gastroenterology Pharmaceuticals Research Lower dose infliximab just as effective as higher doses in ASUC